Brazilian Government to Make Drugs at the Tune of 10 Billion Units

Brazil’s Oswaldo Cruz Foundation plans to increase its production of remedies in its laboratories in Rio de Janeiro from 1.7 billion to 10 billion units. The remedies are distributed free of cost to the population.

The increase in production capacity is due to the purchase, for US$ 6 million, of a laboratory that belonged to the Glaxo do Brasil company.


The executive director of the Fiocruz Institute of Drug Technology, Núbia Boechat, explains that the acquisition of the new factory will reduce the government’s outlays on drug purchases.


“The savings will amount to US$ 3.6 million (10 million reais) with the new laboratory.”


In 2003, the production of Fiocruz’s Farmanguinhos laboratory saved the federal governmnet US$ 72.3 million (200 million reais), she informed.


According to Boechat, the laboratories will manufacture antibiotics, for the first time.


“Since the laboratory that was acquired has elevated technological standards, our production lines will be expanded. At present we work basically in the area of solids and semi-solids, pills, creams, and ointments.


“Now we shall have productions lines for sprays, asthma medicines, and antibiotics,” she explains.


She also underscores the superior quality of the medications produced by Fiocruz.


“Brazil has a very significant pioneering effort. We are the only country in the world with a network of 18 government laboratories, five of them medium in size, all very well organized.


“The medicines are used by the Federal Health System and the government’s programs for needy citizens. Moreover, the government laboratories are the sole producers of drugs for tuberculosis, Chagas’s disease, leishmaniosis, Hansen’s disease, and others.


“These diseases offer no incentive for large pharmaceutical companies, because the profits are low,” she observes.


In Boechat’s opinion, the acquisition of the Glaxo laboratory will directly benefit the Brazilian population.


“We have up-to-date equipment and trained personnel that work from the development of the remedy to quality control. Our motto is to produce high quality remedies for the needy population,” she concludes.


Agência Brasil
Translator: David Silberstein

Tags:

You May Also Like

Brazilians Have Already Spent Close to US$ 3 Billion Overseas this Year

Brazilians expenses abroad have already totaled US$ 653 million this month of May. In ...

Collegeless Join Homeless and Landless in Brazil

The Sans University Movement (MSU) pledges its support and promises that it will be ...

Brazilian Surplus Tumbles Due to Strong Import Growth

Brazilian exports totaled US$ 2.325 billion last week, 3.47% more than in the previous ...

Brazil Petrobras’s US$ 4 Billion in Bonds Pay Up to 7%

State-controlled Brazilian oil and gas multinational Petrobras launched US$ 2.5 billion of 2020 bonds ...

28% of Brazil’s Urban Population Have no Public Water or Sewage

Scarce supply and high prices are Brazil’s chief problems in the housing sector, according ...

Egypt Discovers Brazil’s Medical Market

Egyptian businessmen who visited São Paulo, Brazil, to participate in the Hospitalar – the largest ...

Brazil Thickens the Ranks of Its Middle Class by 40 Million in Less than a Decade

39.5 million Brazilians became part of the middle class between 2003 and May 2011, ...

Brazil’s Emissions Market Is Open for Business

Brazil’s Ministry of Development, Industry, and Foreign Trade (MDIC) and the Commodities and Futures ...

Brazil’s Potiguara and Tumbalalí¡ Indians Protest Against Demarcation Delay

Earlier this month, two indigenous peoples from the Brazilian Northeast were mobilized to sort ...

Lula on Brazil: ‘We Shall Surprise and Grow Over 5%’

Brazilian President Luiz Inácio Lula da Silva once again declared that this year will ...

WordPress database error: [Table './brazzil3_live/wp_wfHits' is marked as crashed and last (automatic?) repair failed]
SHOW FULL COLUMNS FROM `wp_wfHits`